Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & Drugs

| BSE 868.00 -1.05 (-0.12%) | |

BSE Live

Feb 20, 16:01
868.00 -1.05 (-0.12%)
Volume
AVERAGE VOLUME
5-Day
4,295
10-Day
5,403
30-Day
25,763
4,200

  • Prev. Close

    869.05

  • Open Price

    869.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Feb 20, 15:57
869.65 -0.55 (-0.06%)
Volume
AVERAGE VOLUME
5-Day
225,309
10-Day
221,461
30-Day
506,114
113,629

  • Prev. Close

    870.20

  • Open Price

    867.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of Strides Pharma Science (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 48.51 344.37 705.80 497.14 146.44  
Net CashFlow From Operating Activities 204.79 60.06 187.07 288.14 73.25  
Net Cash Used In Investing Activities 1,306.16 -148.49 582.59 -686.69 -2,224.83  
Net Cash Used From Financing Activities -1,709.45 194.27 -1,015.69 338.22 2,943.94  
Foreign Exchange Gains / Losses 14.85 3.90 2.57 3.43 4.21  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 -15.46 -538.77 0.00  
Net Inc/Dec In Cash And Cash Equivalents -183.66 109.73 -258.92 -595.66 796.56  
Cash And Cash Equivalents Begin of Year 365.89 256.16 515.08 1,110.74 314.18  
Cash And Cash Equivalents End Of Year 182.23 365.89 256.16 515.08 1,110.74  
Source : Dion Global Solutions Limited

Results of Strides Pharma

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347
Close Parallel Income Plan 2026